NCT04126122

Brief Summary

In normal pregnancy the spiral arteries in the placental bed are invaded by trophoblast, which becomes incorporated into the vessel wall and replaces the endothelium, muscular layer and neural tissue

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 15, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2020

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

October 15, 2019

Status Verified

October 1, 2019

Enrollment Period

11 months

First QC Date

October 11, 2019

Last Update Submit

October 11, 2019

Conditions

Pre-Eclampsia

Outcome Measures

Primary Outcomes (1)

  • The number of women who will develop adverse outcome

    The women with preeclampsia who will develop eclampsia or pulmonaryb edema

    within 5 months

Interventions

Ultrasonography to assess fetus and motherDIAGNOSTIC_TEST

to assess fetal growth and maternal outcome

Eligibility Criteria

Age20 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant women with preeclampsia
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

pregnant ladies with preeclampsia

You may qualify if:

  • All women with severe preeclampsia

You may not qualify if:

  • History of epilepsy.
  • Patients with chronic hypertension.
  • Patients with renal disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aljazeera( Al Gazeera) hospital

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Central Study Contacts

Mahmoud Alalfy, PhD

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher , lecturer ,Obstetrics and Gynecology , National Research Centre

Study Record Dates

First Submitted

October 11, 2019

First Posted

October 15, 2019

Study Start

February 10, 2019

Primary Completion

January 10, 2020

Study Completion

February 1, 2020

Last Updated

October 15, 2019

Record last verified: 2019-10

Locations

EG(1)